REDWOOD CITY, Calif., Aug. 4, 2015 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that it will report second quarter 2015 financial results after market close on Tuesday, August 11, 2015. Codexis management will hold an investment community conference call at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss financial results and provide a company update.

Live Call: U.S. 855 890 8665
  International 720 634 2938
  Passcode 98456040
     
Live Webcast:Codexis IR Website  
  The webcast will be archived for 30 days.
     
Replay: U.S. 855 859 2056
  International 404 537 3406
  Passcode 98456040
  The replay will be available for 48 hours
   

About Codexis, Inc.

Codexis, Inc. is a leading protein engineering company that applies its technology to the development of biocatalysts for commercial manufacture of pharmaceuticals and fine chemicals. Codexis' proven technology enables implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable manufacturing. For more information, see www.codexis.com.

CONTACT:          Investors
                             LHA
                            Jody Cain, 310 691 7100 
                            jcain@lhai.com

                            Media
                             Notch Communications
                            Kate Whelan, +46 (0)70 238 11 49
                            Kate.whelan@notchcommunications.co.uk

CDXS LOGO